Fatal Mycobacterium peregrinum pneumonia in refractory polymyositis treated with infliximab.
Marie
I
I
Heliot
P
P
Roussel
F
F
Hervé
F
F
Muir
J F
JF
Levesque
H
H
D000368:Aged; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D018501:Antirheumatic Agents / Q000009:adverse effects*; D017809:Fatal Outcome; D006801:Humans; D000069285:Infliximab; D008297:Male; D009165:Mycobacterium Infections, Nontuberculous / Q000139:chemically induced*; D009894:Opportunistic Infections / Q000139:chemically induced; D018410:Pneumonia, Bacterial / Q000139:chemically induced*; D017285:Polymyositis / Q000188:drug therapy*; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors
D000911:Antibodies, Monoclonal; D018501:Antirheumatic Agents; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab